Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM) 2018-08-09T16:47:13+00:00

Project Description

Health Decisions Capabilities for Clinical Studies in the Genitourinary Syndrome of Menopause (GSM)

Health Decisions offers comprehensive clinical development services for therapeutics for the Genitourinary Syndrome of Menopause (GSM), the set of health conditions caused by reduced estrogen levels in postmenopausal women. GSM includes genital symptoms (dryness, burning, irritation), sexual symptoms (lack of lubrication, discomfort or pain, impaired function) and urinary symptoms (urgency, dysuria, recurrent urinary tract infections). Health Decisions understands the challenges of conducting GSM trials, including site selection, patient recruitment and retention and clinical endpoints.

Download PDF
SUBMIT RFP